52 related articles for article (PubMed ID: 19583939)
1. [Protective effect of catechin on renal microvessels in 5/6 nephrectomized rats and its mechanism].
Cao Y; He XJ; Xiang W; Yi ZW
Zhong Xi Yi Jie He Xue Bao; 2009 Jun; 7(6):557-62. PubMed ID: 19583939
[TBL] [Abstract][Full Text] [Related]
2. Effect of angiotensin-converting enzyme two-week inhibition on renal angiotensin II receptors and renal vascular reactivity in SHR.
Haddad G; Garcia R
J Mol Cell Cardiol; 1997 Feb; 29(2):813-22. PubMed ID: 9140837
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin II exerts positive feedback on the intrarenal renin-angiotensin system by an angiotensin converting enzyme-dependent mechanism.
Sadjadi J; Kramer GL; Yu CH; Welborn MB; Modrall JG
J Surg Res; 2005 Dec; 129(2):272-7. PubMed ID: 15992826
[TBL] [Abstract][Full Text] [Related]
4. [Effect of benazepril on the VEGF and MVD in the remnant kidney of 5/6 subtotal nephrectomized rats].
Yao X; Jiang YS; Lin X; Liu GX
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Jan; 33(1):68-73. PubMed ID: 18245908
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin converting enzyme-independent angiotensin ii production by chymase is up-regulated in the ischemic kidney in renovascular hypertension.
Sadjadi J; Kramer GL; Yu CH; Burress Welborn M; Chappell MC; Gregory Modrall J
J Surg Res; 2005 Aug; 127(2):65-9. PubMed ID: 15869764
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic resistance to angiotensin converting enzyme (ACE) inhibition is related to pharmacodynamic and -kinetic factors in 5/6 nephrectomized rats.
Windt WA; van Dokkum RP; Kluppel CA; Jeronimus-Stratingh CM; Hut F; de Zeeuw D; Henning RH
Eur J Pharmacol; 2008 Feb; 580(1-2):231-40. PubMed ID: 18036585
[TBL] [Abstract][Full Text] [Related]
7. Procyanidin structure defines the extent and specificity of angiotensin I converting enzyme inhibition.
Ottaviani JI; Actis-Goretta L; Villordo JJ; Fraga CG
Biochimie; 2006; 88(3-4):359-65. PubMed ID: 16330143
[TBL] [Abstract][Full Text] [Related]
8. Effects of neutral endopeptidase inhibition and combined angiotensin converting enzyme and neutral endopeptidase inhibition on angiotensin and bradykinin peptides in rats.
Campbell DJ; Anastasopoulos F; Duncan AM; James GM; Kladis A; Briscoe TA
J Pharmacol Exp Ther; 1998 Nov; 287(2):567-77. PubMed ID: 9808682
[TBL] [Abstract][Full Text] [Related]
9. Altered angiotensin-converting enzyme and its effects on the brain in a rat model of Alzheimer disease.
Hou DR; Wang Y; Zhou L; Chen K; Tian Y; Song Z; Bao J; Yang QD
Chin Med J (Engl); 2008 Nov; 121(22):2320-3. PubMed ID: 19080340
[TBL] [Abstract][Full Text] [Related]
10. Interaction between neutral endopeptidase and angiotensin converting enzyme inhibition in rats with myocardial infarction: effects on cardiac hypertrophy and angiotensin and bradykinin peptide levels.
Duncan AM; James GM; Anastasopoulos F; Kladis A; Briscoe TA; Campbell DJ
J Pharmacol Exp Ther; 1999 Apr; 289(1):295-303. PubMed ID: 10087017
[TBL] [Abstract][Full Text] [Related]
11. Effects of perindopril on angiotensin converting enzyme in tissues of the rat.
Jackson B; Cubela RB; Johnston CI
J Hypertens Suppl; 1988 Dec; 6(3):S51-4. PubMed ID: 2852236
[TBL] [Abstract][Full Text] [Related]
12. Kinin and angiotensin II receptor antagonists in rats with chronic renal failure: chronic effects on cardio- and renoprotection of angiotensin converting enzyme inhibitors.
Kohzuki M; Kanazawa M; Liu PF; Kamimoto M; Yoshida K; Saito T; Yasujima M; Sato T; Abe K
J Hypertens; 1995 Dec; 13(12 Pt 2):1785-90. PubMed ID: 8903652
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of intrarenal angiotensin II levels in 2 kidney 1 clip and angiotensin II induced hypertension.
Navar LG; Von Thun AM; Zou L; el-Dahr SS; Mitchell KD
Blood Press Suppl; 1995; 2():88-92. PubMed ID: 7582082
[TBL] [Abstract][Full Text] [Related]
14. Effect of cadmium and captopril on serum angiotensin converting enzyme activity in rats.
Puri VN
Indian Heart J; 1997; 49(3):297-9. PubMed ID: 9291654
[TBL] [Abstract][Full Text] [Related]
15. Characterization of a dual inhibitor of angiotensin I-converting enzyme and neutral endopeptidase.
French JF; Flynn GA; Giroux EL; Mehdi S; Anderson B; Beach DC; Koehl JR; Dage RC
J Pharmacol Exp Ther; 1994 Jan; 268(1):180-6. PubMed ID: 8301555
[TBL] [Abstract][Full Text] [Related]
16. Effect of chronic captopril treatment on circulating and tissue renin-angiotensin system in SHR rats.
Hu WY; Chen DG; Chen SC; Jin XQ; Wang HJ
Zhongguo Yao Li Xue Bao; 1996 Nov; 17(6):507-12. PubMed ID: 9863143
[TBL] [Abstract][Full Text] [Related]
17. Protection against ischemia/reperfusion injury and myocardial dysfunction by antisense-oligodeoxynucleotide directed at angiotensin-converting enzyme mRNA.
Chen H; Mohuczy D; Li D; Kimura B; Phillips MI; Mehta P; Mehta JL
Gene Ther; 2001 May; 8(10):804-10. PubMed ID: 11420645
[TBL] [Abstract][Full Text] [Related]
18. Involvement of renal ACE activity in proteinuria-associated renal damage in untreated and treated adriamycin nephrotic rats.
Bos H; Laverman GD; Henning RH; Tiebosch AT; de Jong PE; de Zeeuw D; Navis G
J Renin Angiotensin Aldosterone Syst; 2003 Jun; 4(2):106-12. PubMed ID: 12806593
[TBL] [Abstract][Full Text] [Related]
19. Effects of idrapril calcium on tissue angiotensin-converting enzyme in rats.
Becagli P; Lippi A; Criscuoli M; Breschi MC; Subissi A
J Cardiovasc Pharmacol; 1995 Jul; 26(1):27-32. PubMed ID: 7564361
[TBL] [Abstract][Full Text] [Related]
20. Effect of new peptide inhibitors on the ratio of angiotensin I-converting and kinin-degrading activities of dipeptidyl carboxypeptidase (angiotensin-converting enzyme).
Kalinina EV; Posdnev VF; Komissarova NV; Gomazkov OA
Biochemistry (Mosc); 1997 Mar; 62(3):247-50. PubMed ID: 9275297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
